NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 137 filers reported holding NEKTAR THERAPEUTICS in Q3 2023. The put-call ratio across all filers is 5.78 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $5,535,000 | -48.7% | 239,000 | -52.2% | 0.16% | -62.8% |
| Q4 2019 | $10,793,000 | -46.1% | 500,000 | -54.5% | 0.42% | -48.1% |
| Q3 2019 | $20,037,000 | -29.6% | 1,100,000 | +37.5% | 0.80% | -30.2% |
| Q2 2019 | $28,464,000 | -15.3% | 800,000 | -20.0% | 1.15% | -16.1% |
| Q1 2019 | $33,600,000 | +2.2% | 1,000,000 | 0.0% | 1.37% | +12.7% |
| Q4 2018 | $32,870,000 | -46.1% | 1,000,000 | 0.0% | 1.22% | -23.3% |
| Q3 2018 | $60,960,000 | +4.0% | 1,000,000 | -16.7% | 1.59% | +27.4% |
| Q2 2018 | $58,596,000 | -38.7% | 1,200,000 | +33.3% | 1.24% | +4.0% |
| Q1 2018 | $95,634,000 | +6.8% | 900,000 | -40.0% | 1.20% | -11.4% |
| Q4 2017 | $89,580,000 | +101.8% | 1,500,000 | -18.9% | 1.35% | +76.6% |
| Q3 2017 | $44,400,000 | -5.4% | 1,850,000 | -22.9% | 0.76% | -6.7% |
| Q2 2017 | $46,920,000 | +33.3% | 2,400,000 | +60.0% | 0.82% | +5.0% |
| Q1 2017 | $35,205,000 | +91.3% | 1,500,000 | 0.0% | 0.78% | +91.4% |
| Q4 2016 | $18,405,000 | +7.1% | 1,500,000 | +50.0% | 0.41% | +20.0% |
| Q3 2016 | $17,180,000 | -13.8% | 1,000,000 | -28.6% | 0.34% | -17.3% |
| Q2 2016 | $19,922,000 | -27.6% | 1,400,000 | -30.0% | 0.41% | -23.3% |
| Q1 2016 | $27,500,000 | +2.0% | 2,000,000 | +25.0% | 0.54% | +5.9% |
| Q4 2015 | $26,960,000 | +36.7% | 1,600,000 | -11.1% | 0.51% | +14.7% |
| Q3 2015 | $19,728,000 | -7.2% | 1,800,000 | +5.9% | 0.44% | -51.8% |
| Q2 2015 | $21,267,000 | -3.3% | 1,700,000 | -15.0% | 0.92% | -10.1% |
| Q1 2015 | $22,000,000 | -14.0% | 2,000,000 | +21.2% | 1.02% | +13.4% |
| Q4 2014 | $25,575,000 | +28.4% | 1,650,000 | 0.0% | 0.90% | +22.5% |
| Q3 2014 | $19,916,000 | -27.7% | 1,650,000 | -23.3% | 0.73% | -34.3% |
| Q2 2014 | $27,563,000 | +42.1% | 2,150,000 | +34.4% | 1.12% | +58.8% |
| Q1 2014 | $19,392,000 | +6.8% | 1,600,000 | 0.0% | 0.70% | +7.8% |
| Q4 2013 | $18,160,000 | -24.4% | 1,600,000 | -30.4% | 0.65% | -16.8% |
| Q3 2013 | $24,024,000 | -16.8% | 2,300,000 | -8.0% | 0.78% | -13.9% |
| Q2 2013 | $28,875,000 | – | 2,500,000 | – | 0.91% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rhenman & Partners Asset Management AB | 508,000 | $6,132,000 | 1.80% |
| Bodri Capital Management, LLC | 250,000 | $3,018,000 | 1.46% |
| Granahan Investment Management | 3,442,980 | $41,557,000 | 1.28% |
| TIRSCHWELL & LOEWY INC | 603,441 | $7,284,000 | 1.22% |
| NEA Management Company, LLC | 1,825,600 | $22,035,000 | 1.12% |
| Cormorant Asset Management, LP | 450,000 | $5,432,000 | 1.12% |
| HARVEY CAPITAL MANAGEMENT INC | 221,750 | $2,676,000 | 1.05% |
| Cheyne Capital Management (UK) LLP | 229,577 | $2,772,000 | 0.99% |
| Artal Group S.A. | 1,650,000 | $19,916,000 | 0.73% |
| FIC CAPITAL INC | 147,293 | $1,778,000 | 0.71% |